首页 | 本学科首页   官方微博 | 高级检索  
检索        

肺硬化性血管瘤临床病理特点及免疫表型分析
引用本文:普文静,周子淮,孙振柱.肺硬化性血管瘤临床病理特点及免疫表型分析[J].新疆医科大学学报,2011,34(8):872-875.
作者姓名:普文静  周子淮  孙振柱
作者单位:1. 新疆维吾尔自治区人民医院病理科
2. 新疆医科大学附属肿瘤医院检验科,新疆,乌鲁木齐,830000
摘    要:目的探讨肺硬化性血管瘤(SHL)的临床病理、组织来源及免疫组化特征。方法对5例SHL患者的临床和病理资料进行分析,用TTF-1、CK7、EMA、AEl/AE3、CK5/6、Vimentin、CD31、CD34、S-100、CgA、Syn、NSE、Calretinin、ER、PR、Ki-67共16种抗体进行免疫组化标记。结果肿瘤组织主要由乳头状区、实性区、血管瘤样区和硬化区4种组织形态以不同比例混合构成,瘤细胞主要由立方细胞和多角形/圆形细胞组成。2种细胞共同表达TTF-1和EMA,立方细胞表达AEl/AE3和CK7,多角形/圆形细胞表达Vimentin。结论 SHL的组织形态多样,SHL可能起源于多潜能的原始呼吸道上皮细胞,结合多种免疫组化的标记有助于该病的诊断。

关 键 词:肺硬化性血管瘤  临床病理  免疫组化

Clinical pathological characteristics and immunity phenotype analysis of sclerosing hemangioma of the lung
PU Wen-jing,ZHOU Zi-huai,SUN Zhen-zhu.Clinical pathological characteristics and immunity phenotype analysis of sclerosing hemangioma of the lung[J].Journal of Xinjiang Medical University,2011,34(8):872-875.
Authors:PU Wen-jing  ZHOU Zi-huai  SUN Zhen-zhu
Institution:(Department of Pathology,People′s Hospital of Xinjiang Uygur Autonomous Region,Urumqi 830000,China)
Abstract:Objective To investigate the clinic pathological characteristics and histogenesis of sclerosing hemangioma of the lung(SHL).MethodsThe clinicopathological features of 5 sclerosing hemangiomas were analyzed.Using immunohistochemical methods,the expression of TTF-1,CK7,EMA,AEl/AE3,CK5/6,Vimentin,CD31,CD34,S-100,CgA,Syn,NSE,Calretinin,ER,PR and Ki-67 were observed in 5 cases of SHL.ResultsSHL exhibited the following histological features: papillary,sclerotic,solid,hemorrhagic,and mixed.The majority of tumors s...
Keywords:sclerosing hemangioma of the lung  clinicopathological  immunohistochemistry  
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号